![]() |
Volumn 23, Issue 9, 2009, Pages 1181-
|
Efavirenz and bone health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR PLUS LAMIVUDINE;
CALCIUM;
COLECALCIFEROL;
EFAVIRENZ;
PHENOBARBITAL;
PHENYTOIN;
BONE METABOLISM;
BONE PAIN;
DRUG WITHDRAWAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MYOPATHY;
OSTEOMALACIA;
PRIORITY JOURNAL;
RECOMMENDED DRUG DOSE;
RIB FRACTURE;
RISK ASSESSMENT;
SIDE EFFECT;
VITAMIN D METABOLISM;
VITAMIN SUPPLEMENTATION;
ANTI-HIV AGENTS;
BENZOXAZINES;
CALCIUM;
HUMANS;
OSTEOMALACIA;
VITAMIN D;
|
EID: 67651087477
PISSN: 02699370
EISSN: 14735571
Source Type: Journal
DOI: 10.1097/QAD.0b013e32832bab0f Document Type: Letter |
Times cited : (17)
|
References (7)
|